Skip to main content
NCBI home page
British Journal of Cancer logoLink to British Journal of Cancer
. 1993 Apr;67(4):686–692. doi: 10.1038/bjc.1993.127

Characterisation of UGP and its relationship with beta-core fragment.

A Kardana 1, K D Bagshawe 1, B Coles 1, D Read 1, M Taylor 1
PMCID: PMC1968365  PMID: 8471426

Abstract

Urinary gonadotrophin peptide (UGP) was originally identified by immunoassay in the urine of patients with various types of cancer and by immunohistochemistry in human cancers of various histological types. Extracts of normal adult male urine also contained UGP by immunoassay. Purified UGP from different starting material was subjected to high pressure liquid chromatography (HPLC) prior to defining amino acid sequences. Chromatographed UGP after HPLC showed three distinct fractions. The N-terminal sequence of peptide 2 was completely homologous with the beta-core fragment of human chorionic gonadotrophin (hCG) and this was found associated with two smaller peptides. The N-terminal sequence of peptide 1 has not been described previously whilst the N-terminus of peptide 3 that was sequenced showed complete homology with the N-terminal sequence of eosinophil derived neurotoxin and non-secretory ribonuclease. The monoclonal antibodies 2C2 and 6D3 only bind beta core-fragment (peptide 2) whilst the polyclonal (rabbit) antibody AK12 could bind all three peptides. The radioimmunoassay system using AK12 could be inhibited by all three peptides and the immunoradiometric assay although based on a capture antibody (2C2) that only bound peptide 2, had the potential to measure all three peptides (when bound together as UGP) at the second step when 125I-AK12 was introduced as the detector. A specific radioimmunoassay for peptide 3 was generated using 125I-peptide 3 and the AK12 antibody. Beta core-fragment on iso-electric focusing was found to have a pI > 9.5, peptide 3 showed two bands at pI = 3.5 and 3.8 whilst insufficient purified peptide 1 was available to determine its iso-electric point. Bioassay studies on UGP showed that any biological activity could be attributed to trace contamination with hCG.

Full text

PDF
686

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. ALBERT A. Human urinary gonadotropin. Recent Prog Horm Res. 1956;12:227-96; discussion, 296-301. [PubMed] [Google Scholar]
  2. Akar A. H., Wehmann R. E., Blithe D. L., Blacker C., Nisula B. C. A radioimmunoassay for the core fragment of the human chorionic gonadotropin beta-subunit. J Clin Endocrinol Metab. 1988 Mar;66(3):538–545. doi: 10.1210/jcem-66-3-538. [DOI] [PubMed] [Google Scholar]
  3. Bahl O. P., Carlsen R. B., Bellisario R., Swaminathan N. Human chorionic gonadotropin: amino acid sequence of the alpha and beta subunits. Biochem Biophys Res Commun. 1972 Jul 25;48(2):416–422. doi: 10.1016/s0006-291x(72)80067-6. [DOI] [PubMed] [Google Scholar]
  4. Beintema J. J., Hofsteenge J., Iwama M., Morita T., Ohgi K., Irie M., Sugiyama R. H., Schieven G. L., Dekker C. A., Glitz D. G. Amino acid sequence of the nonsecretory ribonuclease of human urine. Biochemistry. 1988 Jun 14;27(12):4530–4538. doi: 10.1021/bi00412a046. [DOI] [PubMed] [Google Scholar]
  5. Birken S., Armstrong E. G., Kolks M. A., Cole L. A., Agosto G. M., Krichevsky A., Vaitukaitis J. L., Canfield R. E. Structure of the human chorionic gonadotropin beta-subunit fragment from pregnancy urine. Endocrinology. 1988 Jul;123(1):572–583. doi: 10.1210/endo-123-1-572. [DOI] [PubMed] [Google Scholar]
  6. Blithe D. L., Akar A. H., Wehmann R. E., Nisula B. C. Purification of beta-core fragment from pregnancy urine and demonstration that its carbohydrate moieties differ from those of native human chorionic gonadotropin-beta. Endocrinology. 1988 Jan;122(1):173–180. doi: 10.1210/endo-122-1-173. [DOI] [PubMed] [Google Scholar]
  7. Blithe D. L., Wehmann R. E., Nisula B. C. Carbohydrate composition of beta-core. Endocrinology. 1989 Nov;125(5):2267–2272. doi: 10.1210/endo-125-5-2267. [DOI] [PubMed] [Google Scholar]
  8. Brenner B. M., Bohrer M. P., Baylis Ch, Deen W. M. Determinants of glomerular permselectivity: Insights derived from observations in vivo. Kidney Int. 1977 Oct;12(4):229–237. doi: 10.1038/ki.1977.107. [DOI] [PubMed] [Google Scholar]
  9. Caulfield J. P., Farquhar M. G. Distribution of annionic sites in glomerular basement membranes: their possible role in filtration and attachment. Proc Natl Acad Sci U S A. 1976 May;73(5):1646–1650. doi: 10.1073/pnas.73.5.1646. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Chang R. L., Deen W. M., Robertson C. R., Brenner B. M. Permselectivity of the glomerular capillary wall: III. Restricted transport of polyanions. Kidney Int. 1975 Oct;8(4):212–218. doi: 10.1038/ki.1975.104. [DOI] [PubMed] [Google Scholar]
  11. Cole L. A., Wang Y. X., Elliott M., Latif M., Chambers J. T., Chambers S. K., Schwartz P. E. Urinary human chorionic gonadotropin free beta-subunit and beta-core fragment: a new marker of gynecological cancers. Cancer Res. 1988 Mar 1;48(5):1356–1360. [PubMed] [Google Scholar]
  12. Fraker P. J., Speck J. C., Jr Protein and cell membrane iodinations with a sparingly soluble chloroamide, 1,3,4,6-tetrachloro-3a,6a-diphrenylglycoluril. Biochem Biophys Res Commun. 1978 Feb 28;80(4):849–857. doi: 10.1016/0006-291x(78)91322-0. [DOI] [PubMed] [Google Scholar]
  13. Hussa R. O., Fein H. G., Pattillo R. A., Nagelberg S. B., Rosen S. W., Weintraub B. D., Perini F., Ruddon R. W., Cole L. A. A distinctive form of human chorionic gonadotropin beta-subunit-like material produced by cervical carcinoma cells. Cancer Res. 1986 Apr;46(4 Pt 2):1948–1954. [PubMed] [Google Scholar]
  14. Kardana A., Cole L. A. Serum HCG beta-core fragment is masked by associated macromolecules. J Clin Endocrinol Metab. 1990 Nov;71(5):1393–1395. doi: 10.1210/jcem-71-5-1393. [DOI] [PubMed] [Google Scholar]
  15. Kardana A., Taylor M. E., Rowan A. J., Read D. A., Bagshawe K. D. Characterisation of antibodies to urinary gonadotrophin peptide. J Immunol Methods. 1989 Mar 10;118(1):53–58. doi: 10.1016/0022-1759(89)90052-5. [DOI] [PubMed] [Google Scholar]
  16. Kardana A., Taylor M. E., Southall P. J., Boxer G. M., Rowan A. J., Bagshawe K. D. Urinary gonadotrophin peptide--isolation and purification, and its immunohistochemical distribution in normal and neoplastic tissues. Br J Cancer. 1988 Sep;58(3):281–286. doi: 10.1038/bjc.1988.204. [DOI] [PMC free article] [PubMed] [Google Scholar]
  17. Kato Y., Braunstein G. D. Beta-core fragment is a major form of immunoreactive urinary chorionic gonadotropin in human pregnancy. J Clin Endocrinol Metab. 1988 Jun;66(6):1197–1201. doi: 10.1210/jcem-66-6-1197. [DOI] [PubMed] [Google Scholar]
  18. Lefort G. P., Stolk J. M., Nisula B. C. Renal metabolism of the beta-subunit of human choriogonadotropin in the rat. Endocrinology. 1986 Aug;119(2):924–931. doi: 10.1210/endo-119-2-924. [DOI] [PubMed] [Google Scholar]
  19. Nam J. H., Cole L. A., Chambers J. T., Schwartz P. E. Urinary gonadotropin fragment, a new tumor marker. I. Assay development and cancer specificity. Gynecol Oncol. 1990 Mar;36(3):383–390. doi: 10.1016/0090-8258(90)90148-e. [DOI] [PubMed] [Google Scholar]
  20. Papapetrou P. D., Nicopoulou S. C. The origin of a human chorionic gonadotropin beta-subunit-core fragment excreted in the urine of patients with cancer. Acta Endocrinol (Copenh) 1986 Jul;112(3):415–422. doi: 10.1530/acta.0.1120415. [DOI] [PubMed] [Google Scholar]
  21. Rennke H. G., Cotran R. S., Venkatachalam M. A. Role of molecular charge in glomerular permeability. Tracer studies with cationized ferritins. J Cell Biol. 1975 Dec;67(3):638–646. doi: 10.1083/jcb.67.3.638. [DOI] [PMC free article] [PubMed] [Google Scholar]
  22. Searle F., Partridge C. S., Kardana A., Green A. J., Buckley R. G., Begent R. H., Rawlins G. A. Preparation and properties of mouse monoclonal antibody (W14A) to human chorionic gonadotropin. Int J Cancer. 1984 Apr 15;33(4):429–434. doi: 10.1002/ijc.2910330402. [DOI] [PubMed] [Google Scholar]
  23. Van Damme M. P., Robertson D. M., Diczfalusy E. An improved in vitro bioassay method for measuring luteinizing hormone (LH) activity using mouse Leydig cell preparations. Acta Endocrinol (Copenh) 1974 Dec;77(4):655–671. doi: 10.1530/acta.0.0770655. [DOI] [PubMed] [Google Scholar]
  24. Venkatachalam M. A., Rennke H. G. The structural and molecular basis of glomerular filtration. Circ Res. 1978 Sep;43(3):337–347. doi: 10.1161/01.res.43.3.337. [DOI] [PubMed] [Google Scholar]
  25. Wehmann R. E., Nisula B. C. Characterization of a discrete degradation product of the human chorionic gonadotropin beta-subunit in humans. J Clin Endocrinol Metab. 1980 Jul;51(1):101–105. doi: 10.1210/jcem-51-1-101. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Cancer are provided here courtesy of Cancer Research UK

RESOURCES